We examined 29 patients with chronic progressive ganglionopathy of different etiology. Neurophysiological abnormalities were dominated by a widespread decrease in sensory nerve action potential amplitudes, which involved both upper and lower limb nerves, even in patients with asymmetrical or patchy clinical presentation. This impairment of sensory nerve conduction, reflecting a nonlength-dependent pattern of peripheral axon degeneration, should be considered the hallmark of ganglionopathies. The evidence of central sensory pathway impairment, which allows to localize the pathology to the dorsal root ganglion neurons, could be better confirmed by cervical magnetic resonance imaging, which showed a diffuse hyperintensity in the posterior columns in all patients, than by somatosensory evoked potentials, which were undetectable in most of the patients. Few patients showed an impairment of individual motor nerves, which appeared more severe in paraneoplastic associated ganglionopathies. Neurophysiological abnormalities did not appear significantly changed at the 4-year follow-up. We emphasize that distinct abnormalities allow to differentiate ganglionopathies from axonal sensory neuropathies on routine neurophysiological examination.

Keywords:
Ganglionopathy, Sensory neuropathy, Clinical neurophysiology, Nerve conduction
1.
Dalakas MC: Chronic idiopathic ataxic neuropathy. Ann Neurol 1986;19:545–554.
2.
Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, Feldman EL: Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren’s syndrome. Ann Neurol 1990;27:304–315.
3.
Lauria G, Pareyson D, Grisoli M, Sghirlanzoni A: Clinical and MR findings in chronic sensory ganglionopathies. Ann Neurol 2000;47:104–109.
4.
Sterman AB, Schaumburg HH, Asbury AK: The acute sensory neuronopathy syndrome: A distinct clinical entity. Ann Neurol 1980;7:354–358.
5.
Mitsumoto H, Wilbourn AJ: Causes and diagnosis of sensory neuropathies: A review. J Clin Neurophysiol 1994;11:553–567.
6.
Windebank AJ, Blexrud MD, Dyck PJ, Daube JR, Karnes JL: The syndrome of acute sensory neuropathy. Clinical features and electrophysiologic and pathologic changes. Neurology 1990;40:584–591.
7.
Kachi T, Sobue G, Yamamoto M, Igata A: Sensory conduction study in chronic sensory ataxic neuropathy. J Neurol Neurosurg Psychiatry 1994;57:941–944.
8.
Mori K, Koike H, Misu K, Hattori N, Ichimura M, Sobue G: Spinal cord magnetic resonance imaging demonstrates sensory neuronal involvement and clinical severity in neuronopathy associated with Sjögren’s syndrome. J Neurol Neurosurg Psychiatry 2001;71:488–492.
9.
Sobue G, Yasuda T, Kachi T, Sakakibara T, Mitsuma T: Chronic progressive sensory ataxic neuropathy: Clinicopathological features of idiopathic and Sjögren’s syndrome-associated cases. J Neurol 1993;240:1–7.
10.
Illa I, Rojas R, Gallardo E, Serrano C, Graus F: Chronic idiopathic sensory ataxic neuropathy: Immunological aspects of a series of 17 patients. Rev Neurol (Paris) 2001;157:517–522.
11.
Pan CL, Yuki N, Koga M, Chiang MC, Hsieh ST: Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody. Neurology 2001;57:1316–1318.
12.
Waragai M, Tayaka Y, Hayashi M: Serial MR finding of chronic idiopathic ataxic neuropathy. J Neurol Sci 1997;151:93–95.
13.
Willison HJ, O’Leary CP, Veitch J, Blumhardt LD, Busby M, Donaghy M, Fuhr P, Ford H, Hahn A, Renaud S, Katifi HA, Ponsford S, Reuber M, Steck A, Sutton I, Schady W, Thomas PK, Thompson AJ, Vallat JM, Winer J: The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antobodies. Brain 2001;124:1968–1977.
14.
Steck AJ, Erne B, Gabriel JM, Schaeren- Wiemers N: Paraproteinaemic neuropathies. Brain Pathol 1999;9:361–368.
15.
Fisher M: An unusual variant of acute idiopathic polyneuritis (syndrome of acute ophtalmoplegia, ataxia and areflexia). N Eng J Med 1956;255:57–65.
16.
Auger RG, Windebank AJ, Lucchinetti CF, Chalk CH: Role of the blink reflex in the evaluation of sensory neuronopathy. Neurology 1999;53:407–410.
17.
Horwich MS, Cho L, Porro RS, Posner JB: Subacute sensory neuropathy: A remote effect of carcinoma. Ann Neurol 1977;2:7–19.
18.
Yasuda T, Sobue G, Mokuno K, Hakusui S, Ito T, Hirose Y, Yanagi T: Clinico-pathological features of acute autonomic and sensory neuropathy: A long-term follow-up study. J Neurol 1995;242:623–628.
19.
Notermans NC, Wokke JH, Franssen H, van der Graaf Y, Vermeulen M, van den Berg LH, Bar PR, Jennekens FG: Chronic idiopathic polyneuropathy presenting in middle or old age: Clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993;56:1066–1071.
20.
Wokke JHJ, van Dijk GW: Sensory neuropathies including painful and toxic neuropathies. J Neurol 1997;244:209–221.
21.
Yasuda T, Sobue G, Mokuno K, Hakusui S, Ito T, Hirose Y, Yanagi T: Clinico-pathological features of acute autonomic and sensory neuropathy: A long-term follow-up study. J Neurol 1995;242:623–628.
22.
Sobue G, Yasuda T, Kumazawa K, Yamamoto K, Mitsuma T: MRI demonstrated dorsal column involvement of the spinal cord in Sjögren’s syndrome-associated neuropathy. Neurology 1995;45:592–593.
23.
Waragai M, Tayaka Y, Hayashi M: Serial MR finding of chronic idiopathic ataxic neuropathy. J Neurol Sci 1997;151:93–95.
24.
Vorgerd M, Tegenthoff M, Kühne D, Malin JP: Spinal MRI in progressive myeloneuropathy associated with vitamin E deficiency. Neuroradiology 1996;38:S111–S113.
25.
Mascalchi M, Salvi F, Piacentini S, Bartolozzi C: Friedreich’s ataxia: MR findings involving the cervical portion of the spinal cord. AJR Am J Roentgenol 1994;163:187–191.
26.
Okumura R, Asato R, Shimada T, Kusaka H, Mizutani T, Miki Y, Konishi J: Degeneration of the posterior columns of the spinal cord: Postmortem MRI and histopathology. J Comput Assist Tomogr 1992;16:865–867.
27.
Walsh TJ, Clark AW, Parhad IM, Green WR: Neurotoxic effects of cisplatin therapy. Arch Neurol 1982;39:719–720.
28.
Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I, Fabbrica D: Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol 1992;84:364–371.
29.
Amiel H, Gherardi R, Giroux C, Salama J, Breau JL, Delaporte P: Neuropathy caused by cisplatin. 7 cases including one with an autopsy study. Ann Med Interne (Paris) 1987;138:96–100.
30.
Walther PJ, Rossitch E Jr, Bullard DE: The development of Lhermitte’s sign during cisplatin chemotherapy. Possible drug-induced toxicity causing spinal cord demyelination. Cancer 1987;60:2170–2172.
31.
Merchut MP, Adams EM, Morrissey MM: Sensory neuronopathy in autoimmune chronic active hepatitis. Neurology 1993;43:2410–2411.
32.
Sobue G, Yasuda T, Kumazawa K, Yamamoto K, Mitsuma T: MRI demonstrated dorsal columns involvement of the spinal cord in Sjögren’s syndrome-associated neuropathy. Neurology 1995;45:592–593.
33.
Liang BC, Albers JW, Sima AAF, Nostrant TT: Paraneoplastic pseudo-obstruction, mononeuropathy multiplex, and sensory neuronopathy. Muscle Nerve 1994;17:91–96.
34.
Notermans NC, Wokke JHJ, van der Graaf Y, Franssen H, van Dijk GW, Jennekens FGI: Chronic idiopathic axonal polyneuropathy: A five-year follow up. J Neurol Neurosurg Psychiatry 1994;57:1525–1527.
35.
Wolfe GI, Baker NS, Amato AA, Jackson CE, Nations SP, Saperstein DS, Cha CH, Katz JS, Bryan WW, Barohn RJ: Chronic cryptogenenic sensory polyneuropathy. Clinical and laboratory characteristics. Arch Neurol 1999;56:540–547.
36.
Oh SJ, LaGanke C, Claussen GC: Sensory Guillain-Barré syndrome. Neurology 2001;56:82–86.
37.
Rothwell JC, Traub MM, Day BL, Obeso JA, Thomas PK, Marsden CD: Manual motor performances in a deafferentated man. Brain 1982;105:515–542.
38.
Rubin DI, Daube JR: Subacute sensory neuropathy associated with Epstein-Barr virus. Muscle Nerve 1999:22:1607–1610.
39.
Valls-Sole J, Graus F, Font J, Pou A, Tolosa ES: Normal proprioceptive trigeminal afferents in patients with Sjögren’s syndrome and sensory neuronopathy. Ann Neurol 1990;28:786–790.
40.
Auger RG: Role of the masseter reflex in the assessment of subacute sensory neuropathy. Muscle Nerve 1998;21:800–801.
41.
Urban PP, Keilmann A, Teichmann EM, Hopf HC: Sensory neuropathy of the trigeminal, glossopharyngeal, and vagal nerves in Sjögren’s syndrome. J Neurol Sci 2001;186:59–63.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.